BlackRock »

Moleculin Biotech shares owned by BlackRock

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by BlackRock

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1k 491 2.29
2025-12-31 $1.6k 495 3.31

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)

View all positions for BlackRock

Top funds holding Moleculin Biotech

Geode Capital Management
Vanguard Group
Vanguard Capital Management
Hrt Financial
Vanguard Fiduciary Trust
Rockefeller Capital Management
UBS Group
Tower Research Capital
BlackRock
EFG International
Pinnacle Wealth Planning Services
Newbridge Financial Services Group
SBI Securities
Morgan Stanley
Vanguard Global Advisers

View all funds holding Moleculin Biotech